428 related articles for article (PubMed ID: 19187128)
1. Functional expression of human HMG-CoA reductase in Saccharomyces cerevisiae: a system to analyse normal and mutated versions of the enzyme in the context of statin treatment.
Wysocka-Kapcinska M; Lutyk-Nadolska J; Kiliszek M; Plochocka D; Maciag M; Leszczynska A; Rytka J; Burzynska B
J Appl Microbiol; 2009 Mar; 106(3):895-902. PubMed ID: 19187128
[TBL] [Abstract][Full Text] [Related]
2. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
[TBL] [Abstract][Full Text] [Related]
3. Structural mechanism for statin inhibition of HMG-CoA reductase.
Istvan ES; Deisenhofer J
Science; 2001 May; 292(5519):1160-4. PubMed ID: 11349148
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of the karmellae-inducing signal in Hmg1p, a yeast HMG-CoA reductase isozyme.
Profant DA; Roberts CJ; Wright RL
Yeast; 2000 Jun; 16(9):811-27. PubMed ID: 10861905
[TBL] [Abstract][Full Text] [Related]
5. Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Istvan ES
Am Heart J; 2002 Dec; 144(6 Suppl):S27-32. PubMed ID: 12486413
[TBL] [Abstract][Full Text] [Related]
6. Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in human mononuclear leukocytes is regulated coordinately and parallels gene expression in human liver.
Powell EE; Kroon PA
J Clin Invest; 1994 May; 93(5):2168-74. PubMed ID: 8182149
[TBL] [Abstract][Full Text] [Related]
7. Saccharomyces cerevisiae contains two functional genes encoding 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Basson ME; Thorsness M; Rine J
Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5563-7. PubMed ID: 3526336
[TBL] [Abstract][Full Text] [Related]
8. Human hydroxymethylglutaryl-coenzyme A reductase (HMGCR) and statin sensitivity.
Jawaid S; Gertz M; Corsino C; Cheung J; Seidle H; Couch RD
Indian J Biochem Biophys; 2010 Dec; 47(6):331-9. PubMed ID: 21355415
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the class II HMG-CoA reductase of Pseudomonas mevalonii.
Hedl M; Rodwell VW
Protein Sci; 2004 Jun; 13(6):1693-7. PubMed ID: 15152097
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional conservation between yeast and human 3-hydroxy-3-methylglutaryl coenzyme A reductases, the rate-limiting enzyme of sterol biosynthesis.
Basson ME; Thorsness M; Finer-Moore J; Stroud RM; Rine J
Mol Cell Biol; 1988 Sep; 8(9):3797-808. PubMed ID: 3065625
[TBL] [Abstract][Full Text] [Related]
11. Statins and plaque stability.
Gomberg-Maitland M; Fuster V; Fayad ZA; Badimon JJ; Corti R
J Cardiovasc Risk; 2003 Jun; 10(3):161-7. PubMed ID: 12775948
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomics of cholesterol-lowering therapy.
Schmitz G; Langmann T
Vascul Pharmacol; 2006 Feb; 44(2):75-89. PubMed ID: 16337220
[TBL] [Abstract][Full Text] [Related]
13. Sequence comparisons reveal two classes of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Bochar DA; Stauffacher CV; Rodwell VW
Mol Genet Metab; 1999 Feb; 66(2):122-7. PubMed ID: 10068515
[TBL] [Abstract][Full Text] [Related]
14. The regulation of activity of main mevalonic acid pathway enzymes: farnesyl diphosphate synthase, 3-hydroxy-3-methylglutaryl-CoA reductase, and squalene synthase in yeast Saccharomyces cerevisiae.
Szkopińska A; Swiezewska E; Karst F
Biochem Biophys Res Commun; 2000 Jan; 267(1):473-7. PubMed ID: 10623644
[TBL] [Abstract][Full Text] [Related]
15. A paucimorphic variant in the HMG-CoA reductase gene is associated with lipid-lowering response to statin treatment in diabetes: a GoDARTS study.
Donnelly LA; Doney AS; Dannfald J; Whitley AL; Lang CC; Morris AD; Donnan PT; Palmer CN
Pharmacogenet Genomics; 2008 Dec; 18(12):1021-6. PubMed ID: 18815589
[TBL] [Abstract][Full Text] [Related]
16. The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity.
Staal A; Frith JC; French MH; Swartz J; Güngör T; Harrity TW; Tamasi J; Rogers MJ; Feyen JH
J Bone Miner Res; 2003 Jan; 18(1):88-96. PubMed ID: 12510809
[TBL] [Abstract][Full Text] [Related]
17. Protein engineering of the HMG-CoA reductase of Pseudomonas mevalonii. Construction of mutant enzymes whose activity is regulated by phosphorylation and dephosphorylation.
Friesen JA; Rodwell VW
Biochemistry; 1997 Feb; 36(8):2173-7. PubMed ID: 9047317
[TBL] [Abstract][Full Text] [Related]
18. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase activity is inhibited by cholesterol and up-regulated by sitosterol in sitosterolemic fibroblasts.
Honda A; Salen G; Honda M; Batta AK; Tint GS; Xu G; Chen TS; Tanaka N; Shefer S
J Lab Clin Med; 2000 Feb; 135(2):174-9. PubMed ID: 10695663
[TBL] [Abstract][Full Text] [Related]
19. Recombinant Schistosoma mansoni 3-hydroxymethylglutaryl-coenzyme-A reductase has different inhibitor kinetics compared to the mammalian host enzyme.
El-Meanawy A; Hammd H; Chen GZ; Rottman F; Bennett JL
Trop Gastroenterol; 2005; 26(3):132-5. PubMed ID: 16512462
[TBL] [Abstract][Full Text] [Related]
20. Characterization of an HMG-CoA reductase from Listeria monocytogenes that exhibits dual coenzyme specificity.
Theivagt AE; Amanti EN; Beresford NJ; Tabernero L; Friesen JA
Biochemistry; 2006 Dec; 45(48):14397-406. PubMed ID: 17128979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
